Trial Profile
Azilsartan can restore circadian rhythm of the urinary sodium excretion
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2017
Price :
$35
*
At a glance
- Drugs Azilsartan (Primary)
- Indications Hypertension
- Focus Pharmacodynamics
- 03 Nov 2017 Status changed from recruiting to completed.
- 16 Jan 2013 New trial record